Medivie Therapeutic Stock Current Ratio
MDVI Stock | ILA 37.00 0.10 0.27% |
Medivie Therapeutic fundamentals help investors to digest information that contributes to Medivie Therapeutic's financial success or failures. It also enables traders to predict the movement of Medivie Stock. The fundamental analysis module provides a way to measure Medivie Therapeutic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medivie Therapeutic stock.
Medivie |
Medivie Therapeutic Company Current Ratio Analysis
Medivie Therapeutic's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Current Medivie Therapeutic Current Ratio | 0.65 X |
Most of Medivie Therapeutic's fundamental indicators, such as Current Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medivie Therapeutic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Competition |
In accordance with the recently published financial statements, Medivie Therapeutic has a Current Ratio of 0.65 times. This is 77.66% lower than that of the Healthcare sector and 81.43% lower than that of the Medical Instruments & Supplies industry. The current ratio for all Israel stocks is 69.91% higher than that of the company.
Medivie Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medivie Therapeutic's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medivie Therapeutic could also be used in its relative valuation, which is a method of valuing Medivie Therapeutic by comparing valuation metrics of similar companies.Medivie Therapeutic is currently under evaluation in current ratio category among its peers.
Medivie Fundamentals
Return On Equity | -1.56 | |||
Return On Asset | -1.09 | |||
Operating Margin | (24.81) % | |||
Current Valuation | 47.6 M | |||
Shares Outstanding | 2.88 M | |||
Shares Owned By Insiders | 72.29 % | |||
Price To Book | 10.59 X | |||
Price To Sales | 71.11 X | |||
Revenue | 491 K | |||
Gross Profit | (603 K) | |||
EBITDA | (5.16 M) | |||
Net Income | (6.59 M) | |||
Cash And Equivalents | 4.15 M | |||
Cash Per Share | 1.44 X | |||
Total Debt | 3.19 M | |||
Debt To Equity | 0.85 % | |||
Current Ratio | 0.65 X | |||
Book Value Per Share | 1.32 X | |||
Cash Flow From Operations | (3.88 M) | |||
Earnings Per Share | (4.53) X | |||
Number Of Employees | 11 | |||
Beta | -0.32 | |||
Market Capitalization | 4.32 B | |||
Total Asset | 12.19 M | |||
Retained Earnings | (121 M) | |||
Net Asset | 12.19 M |
About Medivie Therapeutic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medivie Therapeutic's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medivie Therapeutic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medivie Therapeutic based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Medivie Stock
Medivie Therapeutic financial ratios help investors to determine whether Medivie Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medivie with respect to the benefits of owning Medivie Therapeutic security.